LGMD2B
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Long-Term Development of Muscular Dystrophy Outcome Assessments (NCT05989620) | Virginia Commonwealth University | 2023-10-18 |
| Deflazacort in Dysferlinopathies (NCT00527228) | Ludwig-Maximilians - University of Munich | 2003-09-01 |
Track LGMD2B automatically
Every clearance here is in the API, with alerts when new ones post.